Investment Summary

Tilia Holdings and Warburg Pincus Invest In Certified Laboratories

On June 1, 2018, private equity firms Tilia Holdings and Warburg Pincus invested in life science company Certified Laboratories

Investment Highlights
  • This is Tilia Holdings’ 2nd and Warburg Pincus’ 25th transaction in the Life Science sector.
  • This is Tilia Holdings’ 2nd and Warburg Pincus’ 183rd transaction in the United States.
  • This is Tilia Holdings’ 1st and Warburg Pincus’ 12th transaction in New York.

Investment Summary
Date 2018-06-01
Target Certified Laboratories
Sector Life Science
Investor(s) Tilia Holdings
Warburg Pincus
Deal Type Growth Capital

Target

Certified Laboratories

Melville, New York, United States
Certified Laboratories is an operator of an independent laboratory comprised of four nationally recognized laboratories located in New York, Illinois, Southern California, and Northern California. Each of these laboratories has developed its own area of expertise and is an acknowledged leader in the field of food analysis with a wide array of clients from mom and pop startups to national, well-known food companies to the FDA. Certified Laboratories was founded in 1926 and is based in Melville, New York.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 2

Investor

Tilia Holdings

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2017
Size Small
Type Sector Agnostic
DESCRIPTION

Tilia Holdings is a private equity firm focused on investing in outsourced business-to-business services providers that serve the food industry. Specific areas of interest include companies that offer regulatory compliance, quality, supply chain integrity or food safety services. The Firm targets companies with at least $10 million of revenue and at least $5 million of EBITDA. Tilia Holdings was established in 2017 and is headquartered in Chicago, Illinois.

DEAL STATS #
Overall 3 of 9
Sector (Life Science) 2 of 2
Type (Growth Capital) 1 of 1
State (New York) 1 of 1
Country (United States) 2 of 8
Year (2018) 3 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-05-17 Labstat

Kitchener, Ontario, Canada

Labstat is a global provider of analytical chemistry and in-vitro toxicology testing services for nicotine containing products. Labstat is a full service contract laboratory dedicated to regulatory and non-regulatory testing. The Company tests all forms of nicotine containing products, including next-generation products such as e-cigarettes and HeatNot-Burn products. Labstat services clients worldwide. With a focus on excellence in science, quality, and responsiveness to clients’ needs, Labstat is ISO 17025 accredited as well as Good Laboratory Practices (GLP) and Good Manufacturing Practices (GMP) compliant. Labstat was founded in 1976 and is based in Kitchener, Ontario.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-11-27 Universal Pure

Lincoln, Nebraska, United States

Universal Pure is a provider of outsourced high-pressure processing (HPP), cold storage and pre-HPP and post-HPP value-added services to help food and beverage companies safely bring longer-lasting, cleaner-label products to market. Universal Pure was founded in 2001 and is based in Lincoln, Nebraska.

Buy -
Investor

Warburg Pincus

New York, New York, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1966
PE ASSETS 83.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Warburg Pincus is a mega-sized, global private equity firm focused on investment opportunities across North America, Asia, and Europe. Warburg will consider investing at various company stages, from early-stage opportunities to distressed situations. Warburg Pincus is organized by industry groups. Verticals include financial services, healthcare, technology, media & telecommunications, energy, consumer & industrial, and real estate. Within financial services, Warburg will consider asset/wealth managers, banks, exchanges, financial technology, insurance, transaction processing, private banking, and specialty/consumer finance. Within healthcare, specific areas of interest include medical devices, healthcare services, and biotech/pharmaceuticals. Within technology/media/communications, Warburg targets software, media/internet/information, financial technology, telecom, business services, and systems/semiconductors. Within energy, specific areas of interest include oil/gas exploration, power generation/transmission, and alternative energy. Warburg Pincus raised its first fund in 1966 and is based in New York City.

DEAL STATS #
Overall 370 of 482
Sector (Life Science) 25 of 27
Type (Growth Capital) 122 of 158
State (New York) 12 of 21
Country (United States) 183 of 237
Year (2018) 19 of 40
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-05-31 Vivtera

Gurgaon, India

Vivtera is a reliable, results driven, global business transformation partner, focused on assisting financial services, insurance and fast growth tech companies gain a significant competitive edge. Vivtera offers complementary skills, domain expertise and a proven track record to create a ‘new age’ global business transformation services organization that is agile in meeting the fast changing needs of global clients. Vivtera was founded in 2018 and is based in Haryana, India.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-06-04 Keystone Dental

Burlington, Massachusetts, United States

Keystone Dental is a provider of dental implant and biomaterial technologies. Keystone Dental delivers advanced, easy-to-use implants, biomaterials and planning software for dental professionals. Keystone Dental was founded in 2006 and is based in Burlington, Massachusetts.

Sell -
Mergr

Product

Company

Legal